Chairs and Speakers – A

Chairs and Speakers – A


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


Susan Abdel-Rahman
Main position/role: Pediatric researcher, innovator, educator, and clinician with 25 years of experience in academic medicine

Dr. Susan Abdel-Rahman is a pediatric researcher, innovator, educator, and clinician with 25 years of experience in academic medicine. She is a former professor of pediatrics and holder of the Marion Merrell Dow/Missouri Chair in Pediatric Clinical Pharmacology. She also directed Health Care Innovation for the Children’s Mercy Research Institute, served as a Section Chief at Children’s Mercy Hospital, directed an NIH funded T32 fellowship program, and provided clinical care on the Clinical Pharmacology consult service before transitioning into her current as Chief Scientific Advisor for a Kansas City-based technology start-up. Dr Rahman chairs the Drug Utilization Review Board for the state of Missouri’s Medicaid program and serves as the immediate past-President of the American Society for Clinical Pharmacology and Therapeutics.


Patriciu Andrei Achimas Cadariu
Main position/role: Professor, University of Medicine and Pharmacy “Iuliu Hatieganu” Cluj-Napoca

Professor, University of Medicine and Pharmacy “Iuliu Hatieganu” Cluj-Napoca, Discipline Surgical Oncology and Gynecologic Oncology,Consultant Physician Gynecologic Oncology and Surgical Oncology, Oncology Institute o’Prof.Dr. Ion Chiricutd ” Cluj-Napoca, Deputy in Chamber of Deputies in The R.omanian Parliament, Secretary of National Health and Family CommissionThe Chamber of DeputiesRomanian Parliament, FormerMinister of Health,The Romanian Ministry of Health, Member,Commission of Oncology,The Romanian Ministry of Health, FormerManager (General Director) Oncology Institute “Prof.Dr. Ion Chiricu{d” Cluj-Napoca, Former Director at the Prorectorate for Research University of Medicine and Pharmacy “Iuliu HaJieganu” cluj-Napoca, Member of the Faculty,university of Ulm, Germany, MSc in Advanced Oncology, Advanced Studies, University of Ulm (Germany), – Associate Member of the Royal College of Obstetricians and Gynaecologists, London,Member of The European Academy of Sciences and Arts, Salzburg, National Representative of TOC (Tumor bank Ovarian Cancer Network), Charite, Berlin, Member of The Romanian Society of Surgery, Romanian Laparoscopy Society, The Romanian Society of Surgical Oncology and Gynecological Oncology, European Society of Gynecological Oncology (ESGO), ::
-Has a richprofessional, teaching and researching activity, coordinating 12 PhD students, 10 graduation papers. Arlicles in extenso in internationally indexed databases: 83 Articles in extenso in national renowned j oumals:29 Over 6500 surgical interventions as a primary surgeon Research focuses in large part on ovarian cancer surgery, evolution and prognostic factors in ovarian cancer, quality of lifb assessment in oncology, cancer in pregnancy.


Sami AlEissa
Main position/role: Speaker

Dr. AlEissa is a consultant Spine Surgeon, associate professor, and the head of orthopedic and spine services at King Abdulaziz Medical City, Riyadh, Saudi Arabia. His main practice involves different aspects of complex spine pathologies. Dr. AlEissa has led the Orthopedic Scientific Council in the SCFHS, Saudi Arabia. He is currently a member of higher medical authority at the Ministry of Health. Dr. AlEissa is the founding president of Saudi Spine Society, and he is a Co-founding member of SPINE20 and the chairman for SPINE20 meeting inaugural in Riyadh, 2020. Dr. AlEissa was awarded King Abdulaziz Medal of Excellence by the order of King Abdullah Bin Abdulaziz.


Pedro Alonso
Main position/role: Professor of Global Health at the Faculty of Medicine, University of Barcelona

2014 and 2022, Prof. Alonso served the World Health Organization (WHO) as director of the Global Malaria Programme (2014-2022). Prior to that, he was the founding director of the Barcelona Institute for Global Health (ISGlobal) (2010), the scientific director leading the establishment of the Manhiça Health Research Center (CISM) in Mozambique (1996) and was part of the leadership team that established the European Developing Countries Clinical Trial Partnership (EDCTP) (2004). He has authored more than 400 papers in peer reviewed journals, with a strong focus on malaria epidemiology, and development and testing of new control tools and strategies, including insecticide treated bed nets, medicines and vaccines. He has also researched other diseases affecting most vulnerable populations particularly in Africa, including tuberculosis, diarrheal diseases and acute respiratory infections, among others. Prof. Alonso has lectured in universities across four continents, has mentored many young scientists and directed more than 25 PhD thesis. Recipient of several national and international awards, including the Ross Medal (University of London), an Honorary International Fellow of the ASTMH, the Frontiers of Knowledge Awards (BBVA) and the Carlo IV Award (Royal Society of Medicine), he has served on several national and international committees and is an Honorary Trustee of the Manhiça Foundation.


Isabella Annesi-Maesano
Main position/role: Research director INSERM (French National Institute of Health and Medical Research)

Isabella Annesi-Maesano is research director at INSERM, the French National Institute of Health and Medical Research, and professor of environmental epidemiology. She is deputy director of the Desbrest Institute of Epidemiology and Public Health, a research unit of INSERM and Montpellier University, and heads the Ethics Committee of the Institute of Research and Development. A respiratory epidemiologist by training, Ms Annesi-Maesano’s research interests lie in explaining the etiopathogenesis of allergic and respiratory diseases, considering environmental risk factors such as air pollution and climate change. She has led several international research projects and served with numerous international medical societies in the field of allergic and respiratory diseases.


Guido Antonelli
Main position/role: Full Professor of “Microbiology and Virology”at the Department of Molecular Medicine –  “Sapienza” University of Rome; Chief of the “Microbiology and Virology” Unit  and  Head of the Department of “Diagnostic Services” at the University Hospital “Policlinico Umberto I”, Rome
He is Full Professor of “Microbiology and Clinical Microbiology” at the Dept of Molecular Medicine – Sapienza University. He took a position at Institute of Virology/Sapienza University (1989) and then at the Department of Biomedicine/University of Pisa (1992).  His group’s research currently focuses on interferons and pathogenesis, control, and diagnosis of several viral infections: SARS- CoV-2, HIV, HCV, main respiratory viruses, and HPV. He participates in several national and international research projects. He has authored and co-authored more than 300 peer-reviewed articles and is now serving as co-editor or member of the editorial board of several peer-reviewed Journals.

Marcello Arca
Main position/role: Full Professor Internal Medicine
Professor Arca has received his degree in Medicine in 1985 and the post-graduate certification in Liver and Metabolic Diseases in 1988, both at Sapienza University of Rome. From 1989-1993 he was holding fellowship positions at the University of Texas, Southwestern Medical Center at Dallas, USA. In 2001, he became Associate Professor of Internal Medicine and in 2019 Full professor of Internal Medicine  at Sapienza University of Rome and Head of the Unit of Internal medicine and Metabolic Disease. at the University Hospital Policlinico Umberto I, Rome , Italy. At present, he is serving as President of the Italian Society for the Study of Atherosclerosis (SISA).

Roberto Ascione
Main position/role: CEO & Founder Healthware Group
Roberto Ascione is a pioneer in digital health and a recognized thought leader, people-inspiring founder, serial entrepreneur and global manager. Roberto is currently CEO at Healthware Group, a global health innovation and technology leader providing transformational advisory and technology services for commercial, medical, and R&D operations of life-sciences and digital health companies, combined with design and development of digital medicines and digital therapeutics products. He is a Founding Member of the Digital Therapeutics Alliance, has been President of the HealthTech Summit, and is Chairman at Frontiers Health, one of the leading digital health conferences globally. Trained as a medical doctor and in marketing communications, his passion for medicine, computer science and human-technology interactions have led to his lifelong commitment and dedication to the advancement and spreading of digital healthcare, he holds a strong belief that digital innovations and technology will be the most impactful drivers of change in healthcare.

Website: robertoascione.com